Minnesota Oncology Hematology — Minneapolis, Minnesota

Minnesota Oncology Hematology is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology has participated in 22 clinical trials with 11 currently active.

Therapeutic areas: Cervical Cancer, Breast Cancer, Metastatic Breast Cancer.

Sponsors: GOG Foundation, Stemline Therapeutics, Inc., USWM CT, LLC.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology?

Minnesota Oncology Hematology has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology conducted?

Minnesota Oncology Hematology has 22 clinical trials on record, with 11 currently active. Their work covers Cervical Cancer, Breast Cancer, Metastatic Breast Cancer.

Is Minnesota Oncology Hematology accredited by Crixeo Health?

Yes — Minnesota Oncology Hematology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Minnesota Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.